The EJA Podcast collection…Q&A with Sander Kempenaers, author of Remimazolam and serious adverse events: A scoping review
Listen to the Q&A with Sander Kempenaers as they discuss the guideline “Remimazolam and serious adverse events: A scoping review”, found in the November 2023 issue of the EJA.